Clik here to view.
rfアイデアズがHIMSS21でヘルスケアパートナーとの協業を紹介
米イリノイ州シャンバーグ （ビジネスワイヤ） — 認証・論理アクセス向け認証情報リーダーの大手メーカーであるrfアイデアズは、HIMSS21の2817番ブースで当社最新のIDアクセス管理ソリューションを展示します。...
View ArticleClik here to view.
rf IDEAS将在HIMSS21展会上展示与医疗合作伙伴的合作成果
伊利诺伊州绍姆堡 (美国商业资讯)–领先的身份验证和逻辑访问凭证阅读器制造商rf IDEAS将在HIMSS21展会2817号展位上展示其最新的身份访问管理解决方案。 此次展会的重点是通过新技术来转变医疗保健行业，rf IDEAS及其合作伙伴将在展会期间重点展示计算机和网络访问、身份访问管理、安全拉印，以及时间和考勤跟踪等方面的最新发展。 今年，rf IDEAS将与惠普、NetIQ...
View ArticleClik here to view.
Aurion Biotech Announces IOTA Cell Therapy Trial
SEATTLE & BOSTON & TOKYO Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of advanced therapies to treat ocular diseases, today announced...
View ArticleClik here to view.
Women in India are the first in the world to receive new heat-stable...
SAINT-PREX, Switzerland After nearly a decade of public-private collaboration, Ferring Pharmaceuticals today announces the first use of heat-stable carbetocin (Carbetocin Ferring) for the prevention...
View ArticleClik here to view.
Adagio Therapeutics Partners with Biocon Biologics to Bring Potent and...
WALTHAM, Mass. Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases...
View ArticleClik here to view.
Dr. Revati Shreeniwas Joins ImmunoMet Therapeutics as Chief Medical Officer
HOUSTON ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-fibrotic and anti-cancer therapies, today announced that Dr. Revati Shreeniwas...
View ArticleClik here to view.
iXensor Levels Up PixoTest® COVID-19 Ag Test With the Launch of PixoHealth...
TAIPEI, Taiwan iXensor Co., Ltd. (6734.TWO) This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210726005852/en/ PixoHealth Pass Admin...
View ArticleClik here to view.
Summit Healthcare Acquisition Corp. Announces the Separate Trading of its...
HONG KONG Summit Healthcare Acquisition Corp. (the “Company”) announced today that, commencing July 30, 2021, holders of the units sold in the Company’s initial public offering of 20,000,000 units,...
View ArticleClik here to view.
lululab Leads K-Beauty Advancement With AI-Based Skincare Solution
SEOUL, South Korea lululab (CEO: Yongjoon Choe), a startup specializing in beauty and healthcare solutions, developed ‘LUMINI,’ an AI-based skin analysis solution, and declared global market entry....
View ArticleClik here to view.
NewQuest Capital Partners Backs Cloudnine, India’s Premium Birthing Center...
SINGAPORE & MUMBAI, India NewQuest Capital Partners (“NewQuest”), the leading dedicated secondary private equity platform focused on the Asia-Pacific region, has announced that it has acquired a...
View ArticleClik here to view.
U.S. Food and Drug Administration Grants Breakthrough Therapy Designation to...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy...
View ArticleClik here to view.
DKT International Announces $1 Billion Commitment to Advance Goals of FP2030
WASHINGTON As COVID-19 continues to put immense pressure on global supply chains making family planning access more critical than ever, DKT International, one of the largest providers of sexual and...
View ArticleClik here to view.
Japan’s Kewpie Corporation, Pioneer of the Hyaluronic Acid Revolution, Has...
TOKYO When the medical application of hyaluronic acid first became widespread 50 years ago, one company, inspired by the idea that the sustenance of life and youth lies within us, dedicated itself...
View ArticleClik here to view.
株式会社KORTUCはピボタル第II相試験（革新的ながん治療放射線増感剤）の加速にむけ、アクサ生命より資金調達を実施
ロンドン & ニューヨーク & 東京 （ビジネスワイヤ） — がんの放射線治療効果を高める放射線増感剤KORTUCの臨床開発及び製品開発を行なうスタートアップ企業、株式会社KORTUC（以下 KORTUC）はアクサ生命保険株式会社（以下 アクサ生命）からの資金調達を実施しました。 KORTUCは本資金調達により、英国で実施中の承認申請取得の為の試験（以下...
View ArticleClik here to view.
KORTUC Inc. Closed Financing From AXA Japan to Accelerate Pivotal Phase II...
LONDON & NEW YORK & TOKYO Today KORTUC Inc., a Japanese clinical-stage biopharmaceutical company focusing on the clinical and product development of a novel radiosensitizer improving the...
View ArticleClik here to view.
Takeda and Frazier Healthcare Partners Announce Collaboration to Launch...
CAMBRIDGE, Mass. & MENLO PARK, Calif. Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (Takeda) and Frazier Healthcare Partners (Frazier) today announced a collaboration to launch...
View ArticleClik here to view.
IWBI 与全球领军企业合作推出 WELL 机构服务商 (WELL EP) 资质
纽约 (美国商业资讯)–国际 WELL 建筑研究院 ( IWBI ) 于今日推出WELL 机构服务商 (WELL Enterprise Provider, 简称 WELL EP ) 资质，这一资质适用于想要在组合资产层面或规模化提供全方位 WELL 解决方案的企业和组织。 WELL EP帮助客户确认并指导实施 WELL 策略，帮助企业在 ESG...
View ArticleClik here to view.
武田和Frazier Healthcare Partners宣布合作成立HilleVax, Inc.以开发临床阶段诺如病毒候选疫苗
马萨诸塞州剑桥和加州门罗帕克 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502/NYSE:TAK)（简称“武田”）和Frazier Healthcare Partners (Frazier)今天宣布合作成立HilleVax, Inc....
View ArticleClik here to view.
GC Pharma Reports Q2 2021 Results
YONGIN, South Korea GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited consolidated financial results for the...
View ArticleClik here to view.
武田薬品とフレーザー・ヘルスケア・パートナーズが臨床段階のノロウイルスワクチン候補を開発する新会社HilleVaxの設立で提携したと発表
米マサチューセッツ州ケンブリッジ & カリフォルニア州メンローパーク （ビジネスワイヤ） — 武田薬品工業株式会社（TSE:4502/NYSE:TAK）（「武田薬品」）とフレーザー・ヘルスケア・パートナーズ（フレーザー）は本日、武田薬品のノロウイルスワクチン候補の開発および商業化を行うバイオ製薬企業のHilleVax,...
View Article